Ciclesonide is well tolerated and has minimal oropharyngeal side effects at once-daily doses of 80 μg, 160 μg, and 320 μg in the treatment of patients with mild-to-moderate asthma
Year: 2004
Type: article
Study design: Clinical Trial
Authors: WE Berger, L Mansfield, C Pinter, J Fish, S Kundu, J Williams, D Banerji, P Hamedani
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2147321005